Oxford’s Inaugural Formulation & Drug Delivery Congress Receives Excellent Feedback

Oxford Global’s Inaugural Formulation & Drug Delivery Congress saw over 150 delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions, attend the two day congress to hear over 35 presentations and case studies focused on the key issues in formulation, drug delivery and product development.

Delegates were able to immerse themselves in 4 interactive streams:
 • Optimising Formulation
 • Improving Drug Delivery
 • Formulation and Drug Delivery Strategies
 • Product Development Considerations

The congress was a success from day one, with delegates and sponsors very happy with the organisation and execution of the event.

Presentations across the two days included:
 • The Development Of An Age Related Medicine (Oral Suspension): Challenges Of Taste
Masking, Bioequivalence And Stability - David Elder, Director, GlaxoSmithKline
 • Applying A Patient Centric Strategy In Design Of New Innovative Products For People With
Psoriasis - Agneta Walhagen, Executive Director, LEO Pharma
 • Influence Of Material Properties On Micronisation Behaviour - Lisa Taylor, Principal Scientist,
Materials Science, Pfizer

Fantastic Feedback…

The congress brought great opportunity for networking and many solution providers and delegates were impressed with the high level calibre of the attendees: “I was impressed by the number of high profile delegates who took part in the event. The topics and presentations were also notable, and the networking opportunities were excellent.Overall, it was very well-organised.’’ - Deputy Head of Industrial Liaison, Diamond LightSource

Many of our solution providers benefited from the networking opportunities with the delegates. “As a solution provider, I liked the way the conference was set up with the amenities for breaks in the same room as the exhibitors. It meant that there was a high footfall to the booth at times, e.g.: lunch, which is normally quiet. This will be the main draw for coming back next year- excellent networking!’’ -Workflow Architect, Freeslate

Delegates enjoyed the flexibility of the congress streams: ''The possibility to choose between the different streams depending on one’s area of interest was particularly notable. There was a very high quality of speakers and presentations. The networking opportunities were also excellent.'' - Lab Head, Merck Serono

Following the event, we analyse statistics and feedback from attendees, and we are proud to announce that we achieved an “Above Average” or “Excellent” rating in all categories including:
 • Relevance and Quality of the Delegates and Solution Providers
 • Organisation of the One-to-one Meetings
 • Format and Content of the Congress Agenda

This is great news for everyone involved in the production of the Formulation & Drug Delivery Congress. One delegate in particular gave great feedback for the congress and team: "I could not fault the congress! Fantastic organisation- it ran smoothly and speakers kept to time, excellent networking opportunities with an impressive range of attendees and speakers”- Pharmacienne Spécialiste en Hydrologie-Bromatologie et Responsable Qualité, Institut Pasteur

After the success of this year’s event, Oxford Global Conferences are pleased to announce that we will be hosting our 2 nd Annual Formulation & Drug Delivery Congress in London in 2016. For further information on attending or sponsoring the event, please contact Danielle Dalby on +44 1865 248455 or by email on d.dalby@oxfordglobal.co.uk